Transfusion Medicine最新文献

筛选
英文 中文
Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study. 医护人员对接受诱导化疗的急性白血病患者出血的看法:定性研究。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-08-01 Epub Date: 2024-07-20 DOI: 10.1111/tme.13070
Shipra Taneja, Nancy M Heddle, Christopher Hillis, Shannon Lane, Meera Karunakaran, Dawn Maze, Dimpy Modi, Dina Khalaf, Donald M Arnold, Hassan Zahreddine, Kathryn Webert, Laura Hess, Richard Cook, Simon Stanworth, Terry Gernsheimer, Meredith Vanstone
{"title":"Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study.","authors":"Shipra Taneja, Nancy M Heddle, Christopher Hillis, Shannon Lane, Meera Karunakaran, Dawn Maze, Dimpy Modi, Dina Khalaf, Donald M Arnold, Hassan Zahreddine, Kathryn Webert, Laura Hess, Richard Cook, Simon Stanworth, Terry Gernsheimer, Meredith Vanstone","doi":"10.1111/tme.13070","DOIUrl":"10.1111/tme.13070","url":null,"abstract":"<p><strong>Background: </strong>Bleeding is a primary outcome for many transfusion-related trials in acute leukaemia (AL) patients, typically graded using the World Health Organisation (WHO) bleeding scale (clinically significant bleed (CSB) is ≥grade 2). This composite outcome fails to differentiate minor bleeds that may not be significant, poorly represents the total burden of bleeding and lacks input from healthcare providers (HCPs) and patients. As part of a multi-step project to create a better bleeding tool for trials, our objective was to identify HCPs' perspectives on the components of CSB in AL patients.</p><p><strong>Study design and methods: </strong>Using qualitative description, we interviewed 19 physicians and nurses who care for AL patients undergoing induction chemotherapy. Participants were recruited from professional organisations, networks and social media. An inductive approach to conventional content analysis was used.</p><p><strong>Results: </strong>HCPs identified features of CSB as the anatomical site of bleeding, amount of bleeding, need for intervention and changes in vital signs. Using these characteristics, bleeding events were categorised into three groups: clinically significant, could evolve into a CSB and not clinically significant. HCPs considered the patient's condition, bleeding history and clinical intuitions when deciding whether a bleed could escalate into serious bleeding.</p><p><strong>Discussion: </strong>Using data from HCPs, we categorised bleeds as clinically significant, could evolve into a CSB, and not significant. A study of patients' perspectives on the importance of different kinds of bleeding is the next step to creating a bleeding definition that is informed by evidence, clinicians and patients.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"268-277"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141731427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BNT162b2 mRNA vaccine in transfusion dependent thalassemia patients. 为输血依赖型地中海贫血患者注射 BNT162b2 mRNA 疫苗。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-08-01 Epub Date: 2024-05-25 DOI: 10.1111/tme.13054
Hinpetch Daungsupawong, Viroj Wiwanitkit
{"title":"BNT162b2 mRNA vaccine in transfusion dependent thalassemia patients.","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.1111/tme.13054","DOIUrl":"10.1111/tme.13054","url":null,"abstract":"","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"329"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of introduction of a goal directed transfusion strategy in a patient blood management program: A single cardiac surgery centre experience. 在患者血液管理计划中引入目标导向输血策略的影响:单个心脏外科中心的经验。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-08-01 Epub Date: 2024-06-30 DOI: 10.1111/tme.13063
Riccardo Fiameni, Matteo Lucchelli, Chiara Novelli, Valentina Salice, Francesca Orsenigo, Mattia Gomarasca, Bedrana MoroSalihovic, Federico Mondin, Giovanni Mistraletti, Ivo Beverina
{"title":"Impact of introduction of a goal directed transfusion strategy in a patient blood management program: A single cardiac surgery centre experience.","authors":"Riccardo Fiameni, Matteo Lucchelli, Chiara Novelli, Valentina Salice, Francesca Orsenigo, Mattia Gomarasca, Bedrana MoroSalihovic, Federico Mondin, Giovanni Mistraletti, Ivo Beverina","doi":"10.1111/tme.13063","DOIUrl":"10.1111/tme.13063","url":null,"abstract":"<p><strong>Background: </strong>The aim of this retrospective and observational study was to analyse the impact of the introduction of a goal directed transfusion (GDT) strategy based on a viscoelastic test (ROTEM®) and specific procoagulant products in a patient blood management (PBM) Program on blood product use and perioperative bleeding in a single cardiac surgery centre.</p><p><strong>Study design and methods: </strong>Patient population underwent cardiac surgery from 2011 to 2021 was divided in two groups based on PBM protocol used (G#11-14, years 2011-2014, G#15-21, years 2015-2021) and compared for the following variables: intraoperative and postoperative transfusions of packed red blood cell and any procoagulant products, postoperative drain blood loss volume and rate of re-exploration surgery. The second program was defined after the introduction of a GDT protocol based on viscoelastic tests and specific procoagulant products.</p><p><strong>Results: </strong>After the introduction of a GDT protocol, about 80% less amongst patients were transfused with fresh frozen plasma and any procoagulant product (p < 0.001 for both phases). Moreover, similar results were obtained with PRBC transfusions (p < 0.001) and drain blood loss volume (p = 0.006) in the postoperative phase. The main factors affecting the use of any procoagulant and PBRC transfusion in the multivariate logistic regression analysis was Group (2 versus 1, OR 0.207, p < 0.001) and preoperative haemoglobin (OR 0.728, p < 0.001), respectively.</p><p><strong>Discussion: </strong>In our experience, a GDT strategy for the diagnosis and treatment of the coagulopathy in patients undergone cardiac surgery led to a significant reduction in bleeding and transfusion.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"257-267"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141470919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of RHC/c genotyping in Chinese Han population. 中国汉族人群中 RHC/c 基因分型的准确性。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-08-01 Epub Date: 2024-05-29 DOI: 10.1111/tme.13056
Shihang Zhou, Ming Liu, Linnan Shao, Wenqian Song, Liying Wang, Yaxin Fan
{"title":"Accuracy of RHC/c genotyping in Chinese Han population.","authors":"Shihang Zhou, Ming Liu, Linnan Shao, Wenqian Song, Liying Wang, Yaxin Fan","doi":"10.1111/tme.13056","DOIUrl":"10.1111/tme.13056","url":null,"abstract":"<p><strong>Background and objectives: </strong>The RHCE gene plays an important role in the complex and polymorphic Rh blood group system. RHCE genotyping holds significant clinical and transfusion-related implications. The objective of this study was to evaluate the accuracy of RHC/c genotyping in the Chinese Han population.</p><p><strong>Materials and methods: </strong>Blood samples were obtained from 653 Chinese Han blood donors. The serological RhD and RhCcEe types were determined using monoclonal antibodies. Subsequently, multiplex real-time polymerase chain reaction (PCR) analysis was performed for RHC and RHc genotyping. Additionally, exon 2 of RHCE and exon 1 of RHD were sequenced.</p><p><strong>Results: </strong>The analysis in this study found 443 RhD-positive donors and 210 RhD-negative donors. Among the 653 total donors, discrepancies between the RHC genotyping results and the serological results were found in 37 individuals. Specifically, 6 false-positive RhC results in RhD-positive donors and 28 false-positive RhC results in RhD-negative donors were identified based on c.48C in RHCE exon 1. Additionally, 3 false-negative RhC results were observed in the RhD-positive donors due to a 109 bp insertion in RHCE intron 2. RHc typing demonstrated complete consistency between the real-time PCR and the serological results.</p><p><strong>Conclusion: </strong>In the Chinese Han population, RHC genotyping was reliable when consistent results were achieved by both c.48C-based and 109 bp insertion-based genotyping. Moreover, RHc genotyping based on c.203A and c.307C polymorphic loci demonstrated dependable performance.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"298-303"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
'Old is gold' does conventional test tube method still reign supreme? An immuno-haematological survey of anti-D detection and titration in ante-natal cases among major hospitals across India. 传统试管法是否仍是 "金科玉律"?印度各大医院产前病例抗 D 检测和滴定的免疫血液学调查。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-08-01 Epub Date: 2024-06-18 DOI: 10.1111/tme.13057
Prashant Pandey, Arghyadeep Marik, Aseem Tiwari, Sudipta Shekhar Das, Shamee Shastry, Mohit Chowdhry, Supriya Kumari
{"title":"'Old is gold' does conventional test tube method still reign supreme? An immuno-haematological survey of anti-D detection and titration in ante-natal cases among major hospitals across India.","authors":"Prashant Pandey, Arghyadeep Marik, Aseem Tiwari, Sudipta Shekhar Das, Shamee Shastry, Mohit Chowdhry, Supriya Kumari","doi":"10.1111/tme.13057","DOIUrl":"10.1111/tme.13057","url":null,"abstract":"<p><strong>Introduction: </strong>Anti-D detection and titration plays a major role in RhD negative antenatal cases both, for monitoring maternal as well as fetal status as well as initiation of early therapeutic interventions, such as intra-uterine transfusions (IUT) to improve maternal as well as fetal morbidity and mortality and reduce the adverse effects of haemolytic disease of fetus and newborn (HDFN). We conducted a survey focusing on the policies and procedures of anti-D detection and titration among major tertiary care centres across India.</p><p><strong>Methodology: </strong>The survey was drafted by a working group of transfusion medicine and immunohematology specialists from six different centres in India. Data were obtained via the use of an online questionnaire.</p><p><strong>Results: </strong>Results were categorised into four categories, Hospital information, immuno-haematological testing methodology, clinical significance of anti-D testing and the role of transfusion medicine specialists. The survey highlighted the modalities as well as the methodologies of anti-D detection and titration in antenatal women across different major tertiary care centres in India.</p><p><strong>Conclusion: </strong>This survey provided a unique snapshot of the prevalent methodologies being employed by major tertiary care centres across the country for detection and titration of anti-D levels as well as the important role it plays in the therapy of affected antenatal women to minimise adverse effects on the fetus.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"278-286"},"PeriodicalIF":1.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour 对成人全血捐献者低铁含量管理策略的快速审查:关注捐献者行为
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-06-21 DOI: 10.1111/tme.13060
Amanda Thijsen, Carley N. Gemelli, Melissa K. Hyde, Rachel Thorpe, Barbara M. Masser
{"title":"A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour","authors":"Amanda Thijsen, Carley N. Gemelli, Melissa K. Hyde, Rachel Thorpe, Barbara M. Masser","doi":"10.1111/tme.13060","DOIUrl":"https://doi.org/10.1111/tme.13060","url":null,"abstract":"In recognition of the impact of whole‐blood donation on body iron stores, there has been an increased focus assessing the efficacy of strategies to minimise the risk of iron deficiency (ID). Whilst donor behaviour is an important determinant of success, this literature is yet to be fully synthesised to help guide blood collection agencies when implementing these strategies into routine practice. This rapid review identifies strategies for management of low iron, how they have been communicated to donors, donor compliance with advice, donor use of external health services and their effect on donor retention. Web of Science, Medline, CINAHL and Wiley online library databases were searched from 2012 to November 2023, with 29 studies meeting inclusion criteria. Five iron management strategies were identified: oral iron supplementation (IS), education, dietary advice, lengthening inter‐donation interval and switching donation type. Most studies (<jats:italic>n</jats:italic> = 16) focused on IS, with only four reporting how they communicated this to donors. Donor use of IS was high in controlled research environments but has not been evaluated when implemented into routine practice. None of the four studies on dietary advice included findings on donor acceptability. The proportion of donors consulting their doctor about a low iron result or their risk of ID was found to be suboptimal. However, in general, the identified strategies and communications had a positive effect on donor retention. More evidence is needed on how to increase donor knowledge and awareness of donation‐related risk of ID as well as to identify how to effectively communicate strategies to donors to ensure optimal acceptability and use.","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":"4 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141505839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence cornered: Transfusion evidence summary-efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion-the PROCOAG randomised clinical trial (JAMA). 证据的角落:输血证据摘要--对有大量输血风险的外伤患者早期使用 4 因子凝血酶原复合物浓缩物的有效性和安全性--PROCOAG 随机临床试验(《美国医学会杂志》)。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-06-01 Epub Date: 2024-03-21 DOI: 10.1111/tme.13035
Josephine McCullagh
{"title":"Evidence cornered: Transfusion evidence summary-efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion-the PROCOAG randomised clinical trial (JAMA).","authors":"Josephine McCullagh","doi":"10.1111/tme.13035","DOIUrl":"10.1111/tme.13035","url":null,"abstract":"","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"169-171"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amber coloured plasma-Case for illustration. 琥珀色等离子体外壳,仅供参考。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-06-01 Epub Date: 2024-05-13 DOI: 10.1111/tme.13047
Amita Radhakrishnan Nair, Baby Saritha Gopalakrishnan, Debasish Gupta
{"title":"Amber coloured plasma-Case for illustration.","authors":"Amita Radhakrishnan Nair, Baby Saritha Gopalakrishnan, Debasish Gupta","doi":"10.1111/tme.13047","DOIUrl":"10.1111/tme.13047","url":null,"abstract":"<p><strong>Introduction: </strong>Abnormal colour of plasma is infrequently identified during processing of blood and blood components. Common reasons include haemolysis, medications or diet related. Sometimes, the aetiology is unknown. It is a dilemma for every transfusion specialist encountering this situation. Effort should be made to find the aetiology of discolouration of plasma, so that the blood donor can be suitably advised, and a decision can be made regarding the use of blood products.</p><p><strong>Materials and methods: </strong>We encountered two cases of orange coloured (amber coloured) plasma in our regular blood donors. All the common reasons for abnormal plasma discolouration were evaluated, including the donor's medication and diet. Spectrophotometry along with Liquid Chromatography-Mass Spectrometry (LC-MS) in both the positive and negative ion modes with literature search helped in arriving at a conclusion.</p><p><strong>Results: </strong>Haemolysis was ruled out by estimation of plasma haemoglobin. Spectrophotometric analysis of the coloured plasma samples showed a peak, which was absent in normal coloured plasma. This was further investigated using Liquid Chromatography-Mass Spectrometry (LC-MS) in both the positive and negative ion modes. There was no significant difference between the coloured and normal samples in the positive ion mode. But in the negative ion mode, there was a peak observed at 110.5 and 191 m/z value in the profile of the coloured samples in comparison with the normal sample. Literature review shows the peak was corresponding to the presence of quinic acid residues-a substance found in coffee, and potentially excreted into the plasma of an individual with high coffee consumption.</p><p><strong>Conclusion: </strong>Reporting unusual causes associated with plasma discolouration is important. Present guidelines forbid issue of abnormal coloured blood and blood components for transfusion. Further such reports are necessary to confirm the safety of recipients receiving such units. This is the first case report to our knowledge of quinic acid discolouring blood products.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"227-230"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140917312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing blood utilization: Experience of blood redistribution policy from a tertiary care hospital based blood centre. 优化血液利用:一家三甲医院血液中心的血液再分配政策经验。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-06-01 Epub Date: 2024-03-27 DOI: 10.1111/tme.13037
Gopal K Patidar, Vidushi Gupta, Anjali Hazarika
{"title":"Optimizing blood utilization: Experience of blood redistribution policy from a tertiary care hospital based blood centre.","authors":"Gopal K Patidar, Vidushi Gupta, Anjali Hazarika","doi":"10.1111/tme.13037","DOIUrl":"10.1111/tme.13037","url":null,"abstract":"","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"231-233"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140294667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene. 一名印度患者因 RHAG 基因中的新型 c.1138 + 2 t > a 突变而出现 Rhnull 表型。
IF 1.5 4区 医学
Transfusion Medicine Pub Date : 2024-06-01 Epub Date: 2024-05-06 DOI: 10.1111/tme.13045
Soumee Banerjee, Ankit Mathur, Neha Hurkat, Santanu Chakraborty, T V Reddy
{"title":"Rh<sub>null</sub> phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene.","authors":"Soumee Banerjee, Ankit Mathur, Neha Hurkat, Santanu Chakraborty, T V Reddy","doi":"10.1111/tme.13045","DOIUrl":"10.1111/tme.13045","url":null,"abstract":"<p><strong>Background: </strong>The Rh system is an extremely important RBC antigen system with over 50 antigens, 5 of which (D, C, E, c and e) are considered most clinically significant. The rare Rhnull phenotype can result from mutations in the RHD and RHCE genes or the RHAG gene that affects their expression. This is a case report of the second type.</p><p><strong>Case report: </strong>This case reports a multiparous lady who had to be evaluated for a panreactive antibody. The discrepancy was first identified at the centre she reported to. A thorough immunohematological workup was performed at a second reference laboratory. Suspecting Rhnull phenotype, a third referral (molecular typing) was requested at International Blood Group Reference Laboratory (IBGRL), Bristol.</p><p><strong>Results: </strong>A novel RHAG null allele (c.1138+2t>a), causing a Rhnull phenotype was identified. The antibody was most likely an anti-Rh 29 antibody.</p><p><strong>Conclusion: </strong>The novel c.1138+2 t > a mutation in the RHAG gene causing the Rhnull phenotype and development of a pan reacting antibody(ies) made the patient's pregnancy challenging. Confirmation of the diagnosis, an important step in her management, required use of both serological immunohematology and molecular techniques.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"223-226"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信